MedPath

Effect of the use of continuous sedation until death on the patient's relatives wellbeing

Recruiting
Conditions
we onderzoeken het welzijn van naasten van een patient die na de toepassing van continue sedatie is overleden
de naasten zelf hebben geen specifieke aandoening
No specific condition
Registration Number
NL-OMON38210
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
625
Inclusion Criteria

The deceased patient:
- Received continuous sedation until death
- Cancer as main diagnosis
- Older than 18 years of age
- Passed away < 6 weeks;Physicians and nurses:
- Involved in decisionmaking of continuous sedation until death ;Relatives
- Concerns familymember or friend
- Fulfills relatives definition NICE guideline: was involved in the care for the patient, shared in the illness experience, and was emotionally involved with the patient before and during the sedation
- Able to speak Dutch and living in the Netherlands

Exclusion Criteria

Not fulfilling the inclusion criteria

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1) Focusgroup study<br /><br>It concerns a qualitative study. Therefore, there are no study parameters in<br /><br>the strict sense. In the focusgroups, the relatives will exchange their<br /><br>experiences with the care for the patient in the last phase of life. Relevant<br /><br>themes will be obtained from their narratives.<br /><br><br /><br>2) Interview study<br /><br>In the interviews, the following topics will be explored:<br /><br>- Patient characteristics<br /><br>- Relative characteristics<br /><br>- Decision-making and communication with the relative<br /><br>- The use of sedation<br /><br>- The patient's quality of dying<br /><br>- Wellbeing of the relative<br /><br><br /><br>3) Questionnaire study<br /><br>Primary study parameters are: satisfaction regarding the dying phase, concerns,<br /><br>grief and aspects of the quality of life after the patient's death (eg physical<br /><br>and mental functioning, role limitations).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1) Focusgroup study<br /><br>Not applicable<br /><br><br /><br>2) Interview study<br /><br>Not applicable<br /><br><br /><br>3) Questionnaire study<br /><br>Secondary study parameters burned-out symptoms, sick-days</p><br>
© Copyright 2025. All Rights Reserved by MedPath